Ahead of World Obesity Day, we examine the impact of the game-changing drugs that control appetite. Increasingly being taken ...
Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a ...
New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...
It’s normal to have lots of questions when you start a new prescription medication. Whether you can drink alcohol might be at ...
Lars Fruergaard Jørgensen is a CEO who didn't want to be CEO but under his tenure Novo Nordisk, which makes Ozempic, has ...
People with a high body weight living in England can now access subsidised weight-loss drugs to treat their obesity.
The popular medications may still suffer from local shortages, but FDA is confident that the national supply will remain ...
19h
Hosted on MSNMore Data Assuage Suicide Concerns With GLP-1 AgentsRisk of suicidality wasn't higher for type 2 diabetes patients starting on GLP-1 receptor agonists than for those on two other popular classes of diabetes drugs, a U.K. cohort study found. In fully ...
These trends reflect a dynamic market where consumers are looking to their drinks to deliver bold experiences, comforting ...
Lars Fruergaard Jørgensen might not be a household name, but his company’s drug Ozempic is. And its success has thrust him — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results